ZA77943B - Topical steroid clindamycin preparations - Google Patents
Topical steroid clindamycin preparationsInfo
- Publication number
- ZA77943B ZA77943B ZA770943A ZA77943A ZA77943B ZA 77943 B ZA77943 B ZA 77943B ZA 770943 A ZA770943 A ZA 770943A ZA 77943 A ZA77943 A ZA 77943A ZA 77943 B ZA77943 B ZA 77943B
- Authority
- ZA
- South Africa
- Prior art keywords
- clindamycin
- preparations
- topical steroid
- steroid
- topical
- Prior art date
Links
- KDLRVYVGXIQJDK-AWPVFWJPSA-N clindamycin Chemical compound CN1C[C@H](CCC)C[C@H]1C(=O)N[C@H]([C@H](C)Cl)[C@@H]1[C@H](O)[C@H](O)[C@@H](O)[C@@H](SC)O1 KDLRVYVGXIQJDK-AWPVFWJPSA-N 0.000 title 1
- 229960002227 clindamycin Drugs 0.000 title 1
- 238000002360 preparation method Methods 0.000 title 1
- 150000003431 steroids Chemical class 0.000 title 1
- 230000000699 topical effect Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
- C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
- C07J5/0061—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16
- C07J5/0069—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
- C07J5/0076—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group by an alkyl group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
- A61K8/602—Glycosides, e.g. rutin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/63—Steroids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Dispersion Chemistry (AREA)
- Birds (AREA)
- Dermatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pain & Pain Management (AREA)
- General Chemical & Material Sciences (AREA)
- Rheumatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US05/668,389 US4018918A (en) | 1975-05-20 | 1976-03-19 | Topical clindamycin preparations |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA77943B true ZA77943B (en) | 1977-12-28 |
Family
ID=24682131
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA770943A ZA77943B (en) | 1976-03-19 | 1977-02-16 | Topical steroid clindamycin preparations |
Country Status (7)
| Country | Link |
|---|---|
| JP (1) | JPS52113954A (show.php) |
| BE (1) | BE852649R (show.php) |
| DE (1) | DE2710880A1 (show.php) |
| FR (1) | FR2344288A2 (show.php) |
| GB (1) | GB1527061A (show.php) |
| NL (1) | NL7702822A (show.php) |
| ZA (1) | ZA77943B (show.php) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU7556291A (en) * | 1990-03-27 | 1991-10-21 | Schering Corporation | Process for 9alpha-hydroxy steroid dehydration |
| JP2648886B2 (ja) * | 1990-10-30 | 1997-09-03 | 日本曹達株式会社 | 家蓄の乳房炎を予防する方法 |
| US6214318B1 (en) | 1997-10-02 | 2001-04-10 | Oms Holdings Llc | Aerosol ointment compositions for topical use |
| ATE257372T1 (de) * | 1997-10-02 | 2004-01-15 | Oms Holdings Llc | Aerosol-salben-zubereitungen |
| RU2190394C1 (ru) * | 2001-11-08 | 2002-10-10 | ОАО Нижегородский химико-фармацевтический завод | Фармацевтический состав, обладающий противогрибковой активностью, и способ его получения |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2365992C3 (de) * | 1972-03-09 | 1982-05-19 | The Upjohn Co., 49001 Kalamazoo, Mich. | 6α-Fluor-17,21-dihydroxy-16β-methylpregna-4,9(11)-dien-3,20-dion-17,21-diacetat und Verfahren zu dessen Herstellung |
-
1977
- 1977-02-16 ZA ZA770943A patent/ZA77943B/xx unknown
- 1977-03-10 GB GB10067/77A patent/GB1527061A/en not_active Expired
- 1977-03-12 DE DE19772710880 patent/DE2710880A1/de not_active Withdrawn
- 1977-03-16 NL NL7702822A patent/NL7702822A/xx not_active Application Discontinuation
- 1977-03-18 JP JP2936277A patent/JPS52113954A/ja active Pending
- 1977-03-18 BE BE175931A patent/BE852649R/xx not_active IP Right Cessation
- 1977-03-18 FR FR7708238A patent/FR2344288A2/fr active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| FR2344288B2 (show.php) | 1980-04-04 |
| NL7702822A (nl) | 1977-09-21 |
| JPS52113954A (en) | 1977-09-24 |
| GB1527061A (en) | 1978-10-04 |
| DE2710880A1 (de) | 1977-09-29 |
| FR2344288A2 (fr) | 1977-10-14 |
| BE852649R (fr) | 1977-09-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU519231B2 (en) | Heparin-liposomes complex | |
| AU511270B2 (en) | Topical spray | |
| PH12183A (en) | Steroid composition for topical application | |
| GB1542347A (en) | Spectrometer | |
| AU508421B2 (en) | Tooch preparations | |
| JPS5285159A (en) | Novel steroid compound | |
| ZA776311B (en) | Improved ointment | |
| AU507804B2 (en) | Topical steroid formulations | |
| GB1539062A (en) | 7-dehydrocholesterol derivatives | |
| AU504800B2 (en) | Gas-cable junction | |
| JPS52148062A (en) | Steroids | |
| AU512101B2 (en) | 19-oxygenated steroids | |
| ZA77943B (en) | Topical steroid clindamycin preparations | |
| JPS51130425A (en) | Colddwaterrsoluble preparations | |
| GB2068227B (en) | Topical ointment | |
| GB2004744B (en) | Immonulogical preparations | |
| AU507072B2 (en) | Reducing zeearalenone | |
| GB1541710A (en) | Anthelintic preparations | |
| AU502977B2 (en) | Valve structure | |
| JPS52117177A (en) | Spectrometer | |
| JPS5345543A (en) | Spectrometer | |
| AU505624B2 (en) | B-homo steroids | |
| GB2148116B (en) | Topical steroid preparations | |
| JPS5297957A (en) | Novel steroid compound | |
| JPS52126276A (en) | Xxray spectrometer |